Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

intervet australia pty limited - bordetella bronchiseptica; canine parainfluenza virus - misc. vaccines or anti sera - bordetella bronchiseptica vaccine-microbial active 0.0 undefined; canine parainfluenza virus vaccine-viral active 0.0 undefined - immunotherapy - dog - over 4 weeks old | puppy - kennel cough | infectious tracheobronchitis

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

intervet australia pty limited - aluminium hydroxide; bordetella bronchiseptica (inactivated cell free extract; canine parainfluenza virus - inactivated - misc. vaccines or anti sera - aluminium hydroxide mineral-aluminium-base active 3.0 mg/do; bordetella bronchiseptica (inactivated cell free extract vaccine-microbial active 0.05 ug/do; canine parainfluenza virus - inactivated vaccine-viral active 0.0 undefined - immunotherapy - dog - with exclusions see label - bordetella bronchiseptica | canine parainfluenza | canine cough syndrome | infectious tracheobronchitis

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

zoetis australia pty ltd - thiomersal; bordetella bronchiseptica (inactivated cell free extract - parenteral liquid/solution/suspension - thiomersal mercury active 0.1 mg/ml; bordetella bronchiseptica (inactivated cell free extract vaccine-microbial active 0.0 u - immunotherapy - dog | bitch | castrate | puppy - bordetella spp. | bordetella bronchiseptica

Philippines - English - FDA (Food And Drug Administration)

zoetis philippines, inc.; distributor: zoetis philippines, inc. - bordetella bronchiseptica vaccine (vet.) - suspension for injection - each ml contains: bordetella bronchiseptica (78-9159 strain) ..... cfu-colony forming unit >3 x 10 cfu

Canada - English - Health Canada

sanofi pasteur limited - pertussis toxoid; filamentous haemagglutinin; fimbriae; pertactin; diphtheria toxoid; tetanus toxoid; inactivated poliomyelitis vaccine (d.c.o.) type 1 mahoney; inactivated poliomyelitis vaccine (d.c.o.) type 2 mef1; inactivated poliomyelitis vaccine (d.c.o.) type 3 saukett - suspension - 20mcg; 20mcg; 5mcg; 3mcg; 15lf; 5lf; 40unit; 8unit; 32unit - pertussis toxoid 20mcg; filamentous haemagglutinin 20mcg; fimbriae 5mcg; pertactin 3mcg; diphtheria toxoid 15lf; tetanus toxoid 5lf; inactivated poliomyelitis vaccine (d.c.o.) type 1 mahoney 40unit; inactivated poliomyelitis vaccine (d.c.o.) type 2 mef1 8unit; inactivated poliomyelitis vaccine (d.c.o.) type 3 saukett 32unit - vaccines

Canada - English - Health Canada

sanofi pasteur limited - pertactin; filamentous haemagglutinin; pertussis toxoid; fimbriae types 2 and 3 (fim); inactivated poliomyelitis vaccine (v.c.o.) type 3 saukett; inactivated poliomyelitis vaccine (v.c.o.) type 2 mef1; inactivated poliomyelitis vaccine (v.c.o.) type 1 mahoney; tetanus toxoid; diphtheria toxoid - suspension - 3mcg; 20mcg; 20mcg; 5mcg; 26unit; 7unit; 29unit; 5lf; 15lf - pertactin 3mcg; filamentous haemagglutinin 20mcg; pertussis toxoid 20mcg; fimbriae types 2 and 3 (fim) 5mcg; inactivated poliomyelitis vaccine (v.c.o.) type 3 saukett 26unit; inactivated poliomyelitis vaccine (v.c.o.) type 2 mef1 7unit; inactivated poliomyelitis vaccine (v.c.o.) type 1 mahoney 29unit; tetanus toxoid 5lf; diphtheria toxoid 15lf

Australia - English - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - poliovirus; pertussis toxoid; pertussis filamentous haemagglutinin; diphtheria toxoid; pertactin; tetanus toxoid -

Singapore - English - HSA (Health Sciences Authority)

sanofi-aventis singapore pte. ltd. - (acellular pertussis) filamentous haemagglutinin adsorbed (fha); (acellular pertussis) fimbriae type 2 and 3 adsorbed (fim); (acellular pertussis) pertactin adsorbed (prn); (acelullar pertussis) pertussis toxoid adsorbed (pt); diphtheria toxoid adsorbed; inactivated poliomyelitis vaccine (ipv) type 1 mahoney; inactivated poliomyelitis vaccine (ipv) type 2 (mef-1); inactivated poliomyelitis vaccine (ipv) type 3 (saukett); tetanus toxoid adsorbed - injection, suspension - (acellular pertussis) filamentous haemagglutinin adsorbed (fha) 5 µg/ 0.5 ml; (acellular pertussis) fimbriae type 2 and 3 adsorbed (fim) 5 µg/0.5 ml; (acellular pertussis) pertactin adsorbed (prn) 3 µg/0.5 ml; (acelullar pertussis) pertussis toxoid adsorbed (pt) 2.5 µg/ 0.5 ml; diphtheria toxoid adsorbed 2lf; inactivated poliomyelitis vaccine (ipv) type 1 mahoney 40 d-antigen units; inactivated poliomyelitis vaccine (ipv) type 2 (mef-1) 8 d-antigen units; inactivated poliomyelitis vaccine (ipv) type 3 (saukett) 32 d-antigen units; tetanus toxoid adsorbed 5lf

Canada - English - Health Canada

glaxosmithkline inc - diphtheria toxoid adsorbed; tetanus toxoid adsorbed; pertussis toxoid adsorbed; filamentous haemagglutinin adsorbed; pertactin adsorbed; inactivated poliovirus type i; inactivated poliovirus type ii; inactivated poliovirus type iii - suspension - 2.5lf; 5.0lf; 8mcg; 8mcg; 2.5mcg; 40d; 8d; 32d - diphtheria toxoid adsorbed 2.5lf; tetanus toxoid adsorbed 5.0lf; pertussis toxoid adsorbed 8mcg; filamentous haemagglutinin adsorbed 8mcg; pertactin adsorbed 2.5mcg; inactivated poliovirus type i 40d; inactivated poliovirus type ii 8d; inactivated poliovirus type iii 32d - vaccines

Canada - English - Health Canada

sanofi pasteur limited - fimbriae; pertactin; diphtheria toxoid; tetanus toxoid; pertussis toxoid; filamentous haemagglutinin - suspension - 5mcg; 3mcg; 15lf; 5lf; 20mcg; 20mcg - fimbriae 5mcg; pertactin 3mcg; diphtheria toxoid 15lf; tetanus toxoid 5lf; pertussis toxoid 20mcg; filamentous haemagglutinin 20mcg - toxoids